KPL

Kwality Pharmaceuticals Share PriceKwality Pharmaceuticals

₹371.05
-1.75 (-0.47%)
As on 06 December, 2023 | 16:52 BSE: 539997 NSE: KPLISIN: INE552U01010

Kwality Pharmaceuticals Performance

Day Range

  • Low
  • High
₹ 371.05

52 Week Range

  • Low
  • High
₹ 371.05
  • Open Price
  • Previous Close
  • Volume

Start SIP in Kwality Pharmaceuticals

Start SIP

Kwality Pharmaceuticals Share Price

  • Over 1 Month 9.37%
  • Over 3 Month -4.03%
  • Over 6 Month 25.74%
  • Over 1 Year 12.51%

Kwality Pharmaceuticals Key Statistics

Kwality Pharmaceuticals Investment Rating

  • Master Rating:
  • M K Proteins has an operating revenue of Rs. 660.58 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 5% is okay, ROE of 21% is exceptional. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 6% and 20% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 45 which is a POOR score indicating inconsistency in earnings, a RS Rating of 51 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 136 indicates it belongs to a poor industry group of Food-Packaged and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Kwality Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 70676956567064
Operating Expenses Qtr Cr 54545741405248
Operating Profit Qtr Cr 15141215161816
Depreciation Qtr Cr 5544433
Interest Qtr Cr 2222111
Tax Qtr Cr 22-23244
Net Profit Qtr Cr 65-7791110
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 254460
Operating Expenses Annual Cr 191284
Operating Profit Annual in Cr 60172
Depreciation Cr 1511
Interest Annual Cr 63
Tax Annual Cr 642
Net Profit Annual Cr 19120
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 4263
Cash from Investing Activity Annual Cr -48-63
Cash from Financing Annual Activity Cr 16
Net Cash Flow Annual Cr -56
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 202183
Fixed Assets Annual Cr 134103
Total Non Current Assets Annual Cr 149115
Total Current Assets Annual Cr 208227
Total Assets Annual Cr 357343
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 195176
ROE Annual % 1066
ROCE Annual % 2177
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2538
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 70676956567064
Operating Expenses Qtr Cr 54545741405248
Operating Profit Qtr Cr 15141115161816
Depreciation Qtr Cr 5544433
Interest Qtr Cr 2222111
Tax Qtr Cr 22-23244
Net Profit Qtr Cr 65-7791110
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 254460
Operating Expenses Annual Cr 191285
Operating Profit Annual in Cr 60172
Depreciation Cr 1511
Interest Annual Cr 63
Tax Annual Cr 642
Net Profit Annual Cr 19120
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 4164
Cash from Investing Activity Annual Cr -48-63
Cash from Financing Annual Activity Cr 16
Net Cash Flow Annual Cr -67
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 201181
Fixed Assets Annual Cr 135104
Total Non Current Assets Annual Cr 146113
Total Current Assets Annual Cr 207228
Total Assets Annual Cr 354341
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 192173
ROE Annual % 1067
ROCE Annual % 2178
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2538

Kwality Pharmaceuticals Technicals

EMA & SMA

Current Price
₹371.05
-1.75 (-0.47%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹368.10
  • 50 Day
  • ₹360.15
  • 100 Day
  • ₹354.96
  • 200 Day
  • ₹353.20
  • 20 Day
  • ₹362.78
  • 50 Day
  • ₹354.17
  • 100 Day
  • ₹361.21
  • 200 Day
  • ₹338.49

Kwality Pharmaceuticals Resistance and Support

PIVOT
₹377.55
Resistance
First Resistance 385.10
Second Resistance 397.40
Third Resistance 404.95
RSI 54.27
MFI 74.46
MACD Single Line 7.92
MACD 9.39
Support
First Resistance 365.25
Second Resistance 357.70
Third Resistance 345.40

Kwality Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 9,092 667,807 73.45
Week 14,462 938,847 64.92
1 Month 15,477 1,174,888 75.91
6 Month 26,969 2,079,873 77.12

Kwality Pharmaceuticals Result Highlights

Kwality Pharmaceuticals Synopsis

NSE-Food-Packaged

M K Proteins belongs to the Industry of Edible Oils & Solvent Extraction. Company’s Total Operating Revenue is Rs. 314.86 Cr. and Equity Capital is Rs. 12.51 Cr. for the Year ended 31/03/2023. M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company’s Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239.
Market Cap 1,119
Sales 405
Shares in Float 3.13
No of funds 1
Yield
Book Value 22.09
U/D Vol ratio 1.2
LTDebt / Equity 5
Alpha 0.16
Beta -0.22

Kwality Pharmaceuticals

Owner NameSep-23Jun-23Mar-23Feb-23
Promoters 74.82%74.82%74.82%74.82%
Foreign Portfolio Investors
Individual Investors 12.27%11.56%11.47%11.45%
Others 12.91%13.62%13.71%13.73%

Kwality Pharmaceuticals Management

Name Designation
Mr. Vinod Kumar Managing Director & CEO
Mr. Raj Kumar Whole Time Director
Mr. Parvind Kumar Non Executive Director
Mr. Parmod Kumar Non Executive Director
Mr. Chatter Singh Ind. Non-Executive Director
Mr. Raman Kumar Sah Ind. Non-Executive Director
Mr. Abhay Kumar Ind. Non-Executive Director
Mr. Dinesh Singh Malik Ind. Non-Executive Director
Ms. Laxmi Mandal Ind. Non-Executive Director

Kwality Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Kwality Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-04 Quarterly Results
2023-08-10 Quarterly Results
2023-05-27 Audited Results
2023-02-14 Quarterly Results
2022-11-14 Quarterly Results

Kwality Pharmaceuticals FAQs

What is Share Price of Kwality Pharmaceuticals ?

Kwality Pharmaceuticals share price is ₹371 As on 06 December, 2023 | 16:38

What is the Market Cap of Kwality Pharmaceuticals ?

The Market Cap of Kwality Pharmaceuticals is ₹385 Cr As on 06 December, 2023 | 16:38

What is the P/E ratio of Kwality Pharmaceuticals ?

The P/E ratio of Kwality Pharmaceuticals is 33.7 As on 06 December, 2023 | 16:38

What is the PB ratio of Kwality Pharmaceuticals ?

The PB ratio of Kwality Pharmaceuticals is 1.9 As on 06 December, 2023 | 16:38

Q2FY23